975
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
622
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
1395
Almost UAH 5 billion. This is the total amount of the fine imposed by the Antimonopoly Committee of Ukraine (AMCU) in its decision No. 370-r dated 31.07.2025 on
1662
Key changes: The government has clarified the 20% sales quota for medicinal products and tightened requirements for pharmacy chains.
1497
LA Law Firm has improved its standing in the "Market Leaders. Ranking of Law Firms — 2025" an annual assessment by the editorial board of Yuridychna Gazeta.
1174
Medical Procurement of Ukraine and the international pharmaceutical company Roche have entered into an investment agreement to localize the manufacturing of oncology medicines in Ukraine.
916
A webinar on 'Revolutionary changes in the regulation of the pharmaceutical market of Ukraine: UPDATE' was recently held, organised by LA Law Firm, with the Apteka.UA Weekly as the media partner.
1498
We are delighted to announce that LA Law Firm has been shortlisted for UKRAINE Firm of the Year in the 2025 awards.
908
LIGA.net, March 21, 2025The extension of patents for the period of martial law creates obstacles to the timely entry of new medicines into the Ukrainian market.
1787
Bolar Exemption allows generic drug manufacturers to start marketing authorization process for a medicinal product before the patent for the generic medicinal product expires.
